192 related articles for article (PubMed ID: 32938950)
1. An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.
Mehta N; Maddineni S; Kelly RL; Lee RB; Hunter SA; Silberstein JL; Parra Sperberg RA; Miller CL; Rabe A; Labanieh L; Cochran JR
Sci Rep; 2020 Sep; 10(1):15171. PubMed ID: 32938950
[TBL] [Abstract][Full Text] [Related]
2. Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation.
Mehta N; Maddineni S; Mathews II; Andres Parra Sperberg R; Huang PS; Cochran JR
Cell Rep; 2019 Sep; 28(10):2509-2516.e5. PubMed ID: 31484064
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis of VSIG3: The Ligand for VISTA.
Xie X; Chen C; Chen W; Jiang J; Wang L; Li T; Sun H; Liu J
Front Immunol; 2021; 12():625808. PubMed ID: 33841409
[TBL] [Abstract][Full Text] [Related]
4. A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors.
Iadonato S; Ovechkina Y; Lustig K; Cross J; Eyde N; Frazier E; Kabi N; Katz C; Lance R; Peckham D; Sridhar S; Talbaux C; Tihista I; Xu M; Guillaudeux T
Front Immunol; 2023; 14():1311658. PubMed ID: 38152397
[TBL] [Abstract][Full Text] [Related]
5. VISTA is an acidic pH-selective ligand for PSGL-1.
Johnston RJ; Su LJ; Pinckney J; Critton D; Boyer E; Krishnakumar A; Corbett M; Rankin AL; Dibella R; Campbell L; Martin GH; Lemar H; Cayton T; Huang RY; Deng X; Nayeem A; Chen H; Ergel B; Rizzo JM; Yamniuk AP; Dutta S; Ngo J; Shorts AO; Ramakrishnan R; Kozhich A; Holloway J; Fang H; Wang YK; Yang Z; Thiam K; Rakestraw G; Rajpal A; Sheppard P; Quigley M; Bahjat KS; Korman AJ
Nature; 2019 Oct; 574(7779):565-570. PubMed ID: 31645726
[TBL] [Abstract][Full Text] [Related]
6. The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma.
Olbromski M; Mrozowska M; Piotrowska A; Smolarz B; Romanowicz H
Cancer Immunol Immunother; 2024 Jun; 73(8):136. PubMed ID: 38833004
[TBL] [Abstract][Full Text] [Related]
7. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.
Wang L; Rubinstein R; Lines JL; Wasiuk A; Ahonen C; Guo Y; Lu LF; Gondek D; Wang Y; Fava RA; Fiser A; Almo S; Noelle RJ
J Exp Med; 2011 Mar; 208(3):577-92. PubMed ID: 21383057
[TBL] [Abstract][Full Text] [Related]
8. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K
MAbs; 2019; 11(4):666-680. PubMed ID: 31046547
[TBL] [Abstract][Full Text] [Related]
9. VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy.
Yuan L; Tatineni J; Mahoney KM; Freeman GJ
Trends Immunol; 2021 Mar; 42(3):209-227. PubMed ID: 33495077
[TBL] [Abstract][Full Text] [Related]
10. VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.
Ceeraz S; Eszterhas SK; Sergent PA; Armstrong DA; Ashare A; Broughton T; Wang L; Pechenick D; Burns CM; Noelle RJ; Vincenti MP; Fava RA
Arthritis Res Ther; 2017 Dec; 19(1):270. PubMed ID: 29216931
[TBL] [Abstract][Full Text] [Related]
11. High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response.
Tao T; Bo L; Li T; Shi L; Zhang H; Ye B; Xu Y; Ma Q; Deng X; Zhang G
Mediators Inflamm; 2021; 2021():6650329. PubMed ID: 34366711
[TBL] [Abstract][Full Text] [Related]
12. VISTA Blockade Aggravates Bone Loss in Experimental Murine Apical Periodontitis.
Yang F; Zhang Y; Chen Z; Zhang L
Front Immunol; 2021; 12():738586. PubMed ID: 34691045
[TBL] [Abstract][Full Text] [Related]
13. Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction.
Mostböck S; Wu HH; Fenn T; Riegler B; Strahlhofer S; Huang Y; Hansen G; Kroe-Barrett R; Tirapu I; Vogt AB
Front Immunol; 2022; 13():862757. PubMed ID: 35967294
[TBL] [Abstract][Full Text] [Related]
14. FOXD3 Regulates VISTA Expression in Melanoma.
Rosenbaum SR; Knecht M; Mollaee M; Zhong Z; Erkes DA; McCue PA; Chervoneva I; Berger AC; Lo JA; Fisher DE; Gershenwald JE; Davies MA; Purwin TJ; Aplin AE
Cell Rep; 2020 Jan; 30(2):510-524.e6. PubMed ID: 31940493
[TBL] [Abstract][Full Text] [Related]
15. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner.
Thakkar D; Paliwal S; Dharmadhikari B; Guan S; Liu L; Kar S; Tulsian NK; Gruber JJ; DiMascio L; Paszkiewicz KH; Ingram PJ; D Boyd-Kirkup J
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35131861
[TBL] [Abstract][Full Text] [Related]
16. VSIG-3 as a ligand of VISTA inhibits human T-cell function.
Wang J; Wu G; Manick B; Hernandez V; Renelt M; Erickson C; Guan J; Singh R; Rollins S; Solorz A; Bi M; Li J; Grabowski D; Dirkx J; Tracy C; Stuart T; Ellinghuysen C; Desmond D; Foster C; Kalabokis V
Immunology; 2019 Jan; 156(1):74-85. PubMed ID: 30220083
[TBL] [Abstract][Full Text] [Related]
17. VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive Resistance.
Schaafsma E; Croteau W; ElTanbouly M; Nowak EC; Smits NC; Deng J; Sarde A; Webber CA; Rabadi D; Cheng C; Noelle R; Lines JL
Cancer Immunol Res; 2023 Jan; 11(1):38-55. PubMed ID: 36260656
[TBL] [Abstract][Full Text] [Related]
18. VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.
ElTanbouly MA; Zhao Y; Nowak E; Li J; Schaafsma E; Le Mercier I; Ceeraz S; Lines JL; Peng C; Carriere C; Huang X; Day M; Koehn B; Lee SW; Silva Morales M; Hogquist KA; Jameson SC; Mueller D; Rothstein J; Blazar BR; Cheng C; Noelle RJ
Science; 2020 Jan; 367(6475):. PubMed ID: 31949051
[TBL] [Abstract][Full Text] [Related]
19. LRIG1 engages ligand VISTA and impairs tumor-specific CD8
Ta HM; Roy D; Zhang K; Alban T; Juric I; Dong J; Parthasarathy PB; Patnaik S; Delaney E; Gilmour C; Zakeri A; Shukla N; Rupani A; Phoon YP; Liu C; Avril S; Gastman B; Chan T; Wang LL
Sci Immunol; 2024 May; 9(95):eadi7418. PubMed ID: 38758807
[TBL] [Abstract][Full Text] [Related]
20. Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
Liu J; Yuan Y; Chen W; Putra J; Suriawinata AA; Schenk AD; Miller HE; Guleria I; Barth RJ; Huang YH; Wang L
Proc Natl Acad Sci U S A; 2015 May; 112(21):6682-7. PubMed ID: 25964334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
